ABIOMED INC Quarterly Deferred Income Tax Liabilities, Net in USD from Q1 2020 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.
Summary
Abiomed Inc quarterly Deferred Income Tax Liabilities, Net history and growth rate from Q1 2020 to Q3 2022.
  • Abiomed Inc Deferred Income Tax Liabilities, Net for the quarter ending September 30, 2022 was $689K, a 17.2% decline year-over-year.
Deferred Income Tax Liabilities, Net, Quarterly (USD)
Deferred Income Tax Liabilities, Net, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 $689K -$143K -17.2% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $735K -$123K -14.3% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $781K -$66K -7.79% Mar 31, 2022 10-Q 2022-11-03
Q4 2021 $799K -$3.5M -81.4% Dec 31, 2021 10-Q 2022-02-03
Q3 2021 $832K -$3.42M -80.4% Sep 30, 2021 10-Q 2021-10-28
Q2 2021 $858K -$3.35M -79.6% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $847K +$41K +5.09% Mar 31, 2021 10-K 2022-05-20
Q4 2020 $4.3M Dec 31, 2020 10-Q 2021-02-04
Q3 2020 $4.25M Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $4.2M Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $806K Mar 31, 2020 10-K 2021-05-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.